Company Overview
Mukka Proteins Limited manufactures and sells fish protein products in India. The company offers fish meal, oil, and soluble paste; and ento meal, oil, and soil. It also provides insect meal, oil, and compost; and humic acid. The company's products are used for aqua feed, poultry feed, pet feed, EPADHA extraction, animal feed, soap manufacture, leather tanneries, and paint industries. It also exports its products to Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam. The company was formerly known as Mukka Sea Food Industries Limited and changed its name to Mukka Proteins Limited in August 2021. The company was founded in 1960 and is based in Mangalore, India.
Why Investors Should Care
Return on capital employed stands at 22.5%.
Trades at a P/E of 13.5, below the sector median of 23.8.
Recent Developments
- Mar 2026 Revenue of ₹1,403.52 Cr (+43.2% YoY); net profit ₹52.06 Cr.
- Trailing 12 Months Year-on-year growth — revenue +43.2%, earnings +12.0%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.7%, profit CAGR 5.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.67% |
| 1 Year: | 43.21% |
Compounded Profit Growth
| 5 Years: | 5.71% |
| 1 Year: | 12.05% |
Stock Price Performance
| 1 Year: | -21.48% |
| 6 Months: | +0.86% |
| 3 Months: | +1.16% |
| 1 Month: | -2.65% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)49.12 · Neutral
P/E of 13.51 is below the sector median of 23.79 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 22.5%.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MUKKA Mukka Proteins Limited NSE | 23.50 | 13.51 | ₹705.00 Cr | 0.00% | 22.50% | 10.43% | 6.67% | 5.71% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,115.10 | 33.05 | ₹4.97 L Cr | 2.05% | 22.15% | 30.86% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 276.25 | 16.73 | ₹3.46 L Cr | 5.68% | 36.47% | 28.53% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,431.80 | 86.10 | ₹2.76 L Cr | 0.82% | 62.44% | 79.99% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 3,911.80 | 85.73 | ₹2.55 L Cr | 0.00% | 16.41% | 12.14% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 469.60 | 52.29 | ₹1.59 L Cr | 0.42% | 19.44% | 15.51% | 17.26% | 26.57% |
| 7 | BRITANNIA Britannia Industries Limited NSE | 5,325.50 | 50.63 | ₹1.28 L Cr | 1.69% | 61.27% | 49.61% | 5.66% | 2.95% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 847.70 | 62.38 | ₹1.10 L Cr | 0.47% | 38.75% | 41.85% | 11.82% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,060.60 | 58.31 | ₹1.09 L Cr | 1.84% | 21.44% | 14.71% | 4.59% | 3.02% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 421.00 Cr | 274.00 Cr | 332.00 Cr | 517.00 Cr | 257.00 Cr | 172.00 Cr | 149.00 Cr | 303.00 Cr | 372.26 Cr | 164.88 Cr | 236.08 Cr | 634.64 Cr | 367.92 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 311.91 Cr | 129.32 Cr | 188.68 Cr | 550.95 Cr | 300.38 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 60.35 Cr | 35.56 Cr | 47.40 Cr | 83.68 Cr | 67.54 Cr |
| Operating Expenses | 378.00 Cr | 260.00 Cr | 294.00 Cr | 498.00 Cr | 224.00 Cr | 159.00 Cr | 140.00 Cr | 262.00 Cr | 33.99 Cr | 24.26 Cr | 30.86 Cr | 42.27 Cr | 38.81 Cr |
| Operating Income | 40.00 Cr | 11.00 Cr | 35.00 Cr | 16.00 Cr | 29.00 Cr | 11.00 Cr | 6.00 Cr | 37.00 Cr | 26.36 Cr | 11.29 Cr | 16.55 Cr | 41.41 Cr | 28.73 Cr |
| EBITDA | 43.00 Cr | 14.00 Cr | 38.00 Cr | 19.00 Cr | 32.00 Cr | 14.00 Cr | 10.00 Cr | 41.00 Cr | 33.24 Cr | 16.66 Cr | 26.28 Cr | 53.21 Cr | 49.18 Cr |
| Interest Expense | 7.00 Cr | 6.00 Cr | 6.00 Cr | 6.00 Cr | 7.00 Cr | 8.00 Cr | 9.00 Cr | 11.00 Cr | 10.31 Cr | 11.04 Cr | 12.82 Cr | 14.56 Cr | 15.17 Cr |
| Pretax Income | 33.00 Cr | 8.00 Cr | 35.00 Cr | 17.00 Cr | 27.00 Cr | 6.00 Cr | 1.00 Cr | 33.00 Cr | 20.10 Cr | 2.36 Cr | 9.28 Cr | 34.62 Cr | 28.89 Cr |
| Tax Provision | 11.22 Cr | 3.60 Cr | 6.30 Cr | 5.27 Cr | -2.16 Cr | 30.00 L | -40.00 L | 6.27 Cr | 6.10 Cr | 77.00 L | 2.39 Cr | 7.37 Cr | 7.53 Cr |
| Net Income | 22.00 Cr | 4.00 Cr | 29.00 Cr | 12.00 Cr | 29.00 Cr | 5.00 Cr | 1.00 Cr | 27.00 Cr | 13.59 Cr | 1.52 Cr | 5.88 Cr | 23.75 Cr | 20.61 Cr |
| Diluted EPS | 0.99 | 0.16 | 1.28 | 0.48 | 0.91 | 0.14 | 0.07 | 0.88 | 0.45 | 0.05 | 0.20 | 0.79 | 0.69 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 409.00 Cr | 549.00 Cr | 604.00 Cr | - | 1,156.36 Cr | 1,342.11 Cr | 980.03 Cr | 1,403.52 Cr |
| Cost of Revenue | - | - | - | - | 985.45 Cr | 1,169.59 Cr | 774.67 Cr | 1,169.33 Cr |
| Gross Profit | - | - | - | - | 170.91 Cr | 172.51 Cr | 205.36 Cr | 234.19 Cr |
| Operating Expenses | 385.00 Cr | 525.00 Cr | 582.00 Cr | - | 90.55 Cr | 79.24 Cr | 124.02 Cr | 136.20 Cr |
| Operating Income | 21.00 Cr | 19.00 Cr | 14.00 Cr | - | 80.36 Cr | 93.28 Cr | 81.33 Cr | 97.99 Cr |
| EBITDA | 23.00 Cr | 24.00 Cr | 22.00 Cr | - | 89.46 Cr | 118.79 Cr | 111.07 Cr | 145.33 Cr |
| Interest Expense | 4.00 Cr | 7.00 Cr | 8.00 Cr | - | 11.62 Cr | 18.99 Cr | 37.25 Cr | 53.60 Cr |
| Pretax Income | 19.00 Cr | 20.00 Cr | 15.00 Cr | - | 65.94 Cr | 87.46 Cr | 60.27 Cr | 75.14 Cr |
| Tax Provision | 5.13 Cr | 6.20 Cr | 4.35 Cr | - | 18.42 Cr | 13.15 Cr | 12.17 Cr | 18.06 Cr |
| Net Income | 14.00 Cr | 14.00 Cr | 11.00 Cr | - | 44.08 Cr | 70.05 Cr | 46.46 Cr | 52.06 Cr |
| Diluted EPS | - | - | - | - | 1.47 | 3.10 | 1.55 | 1.74 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 201.00 Cr | 293.00 Cr | 355.00 Cr | - | 575.16 Cr | 940.79 Cr | 1,076.32 Cr | 1,621.13 Cr |
| Current Assets | - | - | - | - | 464.04 Cr | 816.52 Cr | 925.72 Cr | 1,288.83 Cr |
| Cash & Equivalents | - | - | - | - | 26.55 Cr | 94.44 Cr | 3.08 Cr | 12.88 Cr |
| Inventory | - | - | - | - | 229.77 Cr | 423.25 Cr | 564.25 Cr | 856.55 Cr |
| Receivables | - | - | - | - | 113.27 Cr | 185.34 Cr | 199.82 Cr | 181.83 Cr |
| Total Liabilities | - | - | - | - | 419.32 Cr | 532.49 Cr | 619.82 Cr | 1,092.35 Cr |
| Current Liabilities | - | - | - | - | 402.80 Cr | 520.93 Cr | 610.41 Cr | 1,048.93 Cr |
| Long Term Debt | - | - | - | - | 5.36 Cr | 6.39 Cr | 2.52 Cr | 32.10 Cr |
| Total Debt | 83.00 Cr | 142.00 Cr | 159.00 Cr | - | 261.85 Cr | 365.27 Cr | 452.91 Cr | 779.29 Cr |
| Total Equity | 44.00 Cr | 57.00 Cr | 67.00 Cr | - | 147.80 Cr | 396.09 Cr | 440.70 Cr | 499.09 Cr |
| Shares Outstanding | - | - | - | - | 30.00 Cr | 30.00 Cr | 30.00 Cr | 30.00 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.00 Cr | -25.00 Cr | 2.00 Cr | - | -56.33 Cr | -150.41 Cr | -111.93 Cr | -111.27 Cr |
| Investing Cash Flow | -23.00 Cr | -28.00 Cr | -14.00 Cr | - | -3.33 Cr | -47.59 Cr | -34.99 Cr | -145.98 Cr |
| Financing Cash Flow | 34.00 Cr | 54.00 Cr | 13.00 Cr | - | 74.67 Cr | 265.89 Cr | 55.55 Cr | 267.06 Cr |
| Capital Expenditure | -19.00 Cr | -36.00 Cr | -10.00 Cr | - | -8.21 Cr | -15.61 Cr | -20.04 Cr | -120.55 Cr |
| Free Cash Flow | -39.00 Cr | -61.00 Cr | -8.00 Cr | - | -64.54 Cr | -166.02 Cr | -131.97 Cr | -231.81 Cr |
| Net Change in Cash | -9.00 Cr | 1.00 Cr | 2.00 Cr | - | 15.01 Cr | 67.89 Cr | -91.36 Cr | 9.81 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | 14.8% | 12.9% | 21.0% | 16.7% |
| Operating Margin % | 5.1% | 3.5% | 2.3% | - | 6.9% | 7.0% | 8.3% | 7.0% |
| Net Margin % | 3.4% | 2.6% | 1.8% | - | 3.8% | 5.2% | 4.7% | 3.7% |
| ROE % | 31.8% | 24.6% | 16.4% | - | 29.8% | 17.7% | 10.5% | 10.4% |
| ROCE % | - | - | - | - | 46.6% | 22.2% | 17.5% | 17.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MUKKA
Mukka Proteins defers Vietnam arm acquisition amid regulatory approval delays - ETLegalWorld.com
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxObWhqamprc2FmWURSOWNVeDFoeF9GUndrMGlFc0tHNTMwMU5DSnNkX3JXc2hDY0N0ajV3NmRWSG9YTV84TDdkN0EtNmNMWXRGRFg3Mlpwd2txR2xBQnc1elIzWTVyYVNMbFdQNllfdDRCbnNoczR2ekJMMGgtcnJHdXd5RjZDT3dhNkMtcH…
Mukka Proteins Acquires 51% Stake in Delta Marine Products; Shares Decline - HDFC Sky
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQZ3hoQ0Z1SjlwM2wxZFBjbVNLWUtya1pUbVI4T1FmVVpBeTFjZzl2Tkh6SW9kd1BwT0IyTkQtT1NfMlFnaFBRYndFOXVPTkd3QmFfOUpCbFA5aVV0bXBUaHN5WXdNeVNNOGtsR1BXQklSU0FTN3JMR0RBcGRzeVZQVXM2dzlIMUFXVHJ5bk…
Here's Why Mukka Proteins (NSE:MUKKA) Has A Meaningful Debt Burden - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxQc0JHNmw5Q3N0V2RnUjlfRjhuOGdpUVdmX2FKQ1Z4VzdVcTZ5ZEIzNkpUUG5BMlNldlpUM2JTb0VVOGtkRnFMaGpsOWdHVjQtbS1fZXhmWFJrU2ZVRHZCeXh2eW1pT2tVcU4tbjdKUm1yVVphQjN1WHpUZkJEN1c5WDYtSUY4a3lZbXo2Yk…
Mukka Proteins confirms no encumbrance on promoter shares in FY26 - scanx.trade
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQSjRMSEdJODBVVXpfWkRFaWhNNWdXN3d0MlFmRHNkRl8zY1BKUHVGY3BXOTZpTDVscGF0MVFfaUNUMlJUcjVLa0F4WXZOQmZKMW5BUnpzVGV1d21TMzBwMklDZlJUWmhfeWNsRmZEaUJISzBMMThvSlFQVjY3RldPM2cyNEI0Qm1VbDV5Sm…
Mukka Proteins shares hit 20% upper circuit as JV wins ₹474-crore order - Business Standard
<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxPdmdVelhGaVJwRnB5TDdUSlJWLXUwMzFHLV9uVGR1TVk1Sk9RS0JyQi1mOEJKdjFTV0hDTWdNaTZoYVoyT3NpQ0tPU2VBd2VXd3RRX2tZd2xENTMxY0tmSl9RMEVfNm02a3N1ZnE2d0d0Vm83OENyeVJ4V3l0SGhxRDBBM1BWOENPLW9qUH…
Stocks to Watch Today: Pine Labs, Rail Vikas Nigam, Mukka Proteins, Pace Digitek, InterGlobe Aviation,... - Moneycontrol.com
<a href="https://news.google.com/rss/articles/CBMinAJBVV95cUxPLWYxRWRPaVhmWm83Q2pqd0hJX1lhLXJ1WkpUR1RpYU9WMHp3RFJISzM2aktkSUx5SHZkWTRxczlpYTJfamNqck5CMzA0ek1LSFgyRlE2OGQwMDJHUlFHaEtjV0pZd1VXQ01KczNscUxhSVZiRTZFMHA2VFk0ZXpvWkZ1dG5vemp1dExKRD…
MUKKA — Frequently Asked Questions
What is the current share price of Mukka Proteins Limited (MUKKA)?
As of 2026-07-15 09:52 IST, Mukka Proteins Limited (MUKKA) trades at ₹23.50 on NSE. Its 52-week range is ₹18.49 to ₹30.01.
What is the market capitalisation of MUKKA?
Mukka Proteins Limited (MUKKA) has a market capitalisation of ₹705.00 Cr on NSE.
What is the P/E ratio of MUKKA?
MUKKA trades at a trailing price-to-earnings (P/E) ratio of 13.51. The industry average P/E is 23.79. Its price-to-book (P/B) ratio is 1.44.
What is the return on equity (ROE) of MUKKA?
MUKKA has a return on equity (ROE) of 10.43%. Its return on capital employed (ROCE) is 22.50%.
Is MUKKA a good stock to buy?
This page provides a data-driven analysis of Mukka Proteins Limited (MUKKA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.